Journal of Practical Hepatology ›› 2022, Vol. 25 ›› Issue (3): 403-406.doi: 10.3969/j.issn.1672-5069.2022.03.025

• Liver cirrhosis • Previous Articles     Next Articles

Clinical feature of patients with primary biliary cholangitis and primary biliary cirrhosis

Yuan Hui, Li Yuwen, Li Jun, et al   

  1. Department of Infectious Diseases, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
  • Received:2021-10-03 Online:2022-05-10 Published:2022-05-17

Abstract: Objective The aim of this study was to compare the clinical feature of patients with primary biliary cholangitis and primary biliary cirrhosis. Methods 164 patients, including 70 with primary biliary cholangitis and 94 with primary biliary cirrhosis were encountered in the First Affiliated Hospital, Nanjing Medical University between May 2015 and September 2021, and their clinical materials were reviewed. The Logistic regression analysis was applied to investigate the risk factors for disease progression in this kind of patients. Result The age of the patients with cirrhosis was ( 58.6±13.0) year-old, significantly greater than [( 53.4± 11.1) year-old, P<0.05] in patients without cirrhosis; serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and total bilirubin levels in patients with cirrhosis were 49.7(27.5, 80.2) U/L, 62.6(44.9, 114.7) U/L, 156.8(126.5, 230.5) U/L and 31.5 (17.6, 88.4) μmol/L, significantly higher than [39.3(23.9, 66.0) U/L, 36.4(26.8, 63.4) U/L, 126.5(94.8, 187.3) U/L and 14.6(10.0, 24.3) μmol/L, respectively, P<0.05] in patients with primary biliary cholangitis; the positive rates of serum anti-nuclear antibody and anti gp210 antibody in patients with primary biliary cirrhosis were 91.5% and 43.6%, significantly higher than 80.0% and 25.7%(P<0.05) in patients with primary biliary cholangitis; serum IgG, IgA and IgM levels in patients with primary biliary cirrhosis were 17.0(13.2, 20.9) g/L, 3.5(2.5, 4.8) g/L and 2.9(2.0, 4.8) g/L, significantly higher than [14.2(12.7, 15.8) g/L、2.6(2.0, 3.4) g/L and 1.8(1.2, 3.3) g/L, respectively, P<0.05], while serum C3 and C4 levels were 0.7(0.5, 0.9) g/L and 0.1(0.1, 0.2) g/L, significantly lower than [1.2(1.1, 1.4) g/L and 0.2(0.2, 0.3) g/L, respectively, P<0.05] in patients with primary biliary cholangitis; the multivariate Logistic analysis showed that increased serum IgM and decreased C4 levels were the independent risk factors for the occurrence of liver cirrhosis (P<0.05). Conclusion Some feature could hint the liver cirrhosis in patients with primary biliary cholangitis, out of them, higher serum IgM and low serum complement C4 levels might be the easy parameters.

Key words: Primary biliary cholangitis, Immunoglobulin, Complement C4